Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2089288
Max Phase: Preclinical
Molecular Formula: C36H44ClN3O3S
Molecular Weight: 634.29
Molecule Type: Small molecule
Associated Items:
ID: ALA2089288
Max Phase: Preclinical
Molecular Formula: C36H44ClN3O3S
Molecular Weight: 634.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)[C@]2(C)CC[C@@H](CS(=O)(=O)NC(=O)c3ccc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)cc3)[C@@]1(C)C2
Standard InChI: InChI=1S/C36H44ClN3O3S/c1-34(2)35(3)18-17-29(36(34,4)25-35)24-44(42,43)38-33(41)27-11-15-31(16-12-27)40-21-19-39(20-22-40)23-28-7-5-6-8-32(28)26-9-13-30(37)14-10-26/h5-16,29H,17-25H2,1-4H3,(H,38,41)/t29-,35+,36+/m0/s1
Standard InChI Key: YAIFIQIAZOILGN-BXQIBZSOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 634.29 | Molecular Weight (Monoisotopic): 633.2792 | AlogP: 7.24 | #Rotatable Bonds: 8 |
Polar Surface Area: 69.72 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.08 | CX Basic pKa: 8.35 | CX LogP: 6.01 | CX LogD: 6.08 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.28 | Np Likeness Score: -0.58 |
1. Yusuff N, Doré M, Joud C, Visser M, Springer C, Xie X, Herlihy K, Porter D, Touré BB.. (2012) Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction., 3 (7): [PMID:24900514] [10.1021/ml300095a] |
Source(1):